These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26068309)

  • 1. High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study.
    Shlomai G; Haran-Appel T; Sella T; Grossman Y; Hauschner H; Rosenberg N; Grossman E
    Cardiovasc Diabetol; 2015 Jun; 14():80. PubMed ID: 26068309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.
    Tarnow I; Michelson AD; Barnard MR; Frelinger AL; Aasted B; Jensen BR; Parving HH; Rossing P; Tarnow L
    Platelets; 2009 Nov; 20(7):513-9. PubMed ID: 19852691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean Platelet Volume and Platelet Count in Patients with Type 2 Diabetes Mellitus and Impaired Fasting Glucose.
    Bhatta S; Singh S; Gautam S; Osti BP
    J Nepal Health Res Counc; 2019 Jan; 16(41):392-395. PubMed ID: 30739927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus.
    Zhou AM; Xiang YJ; Liu EQ; Cai CH; Wu YH; Yang LB; Zeng CL
    BMC Cardiovasc Disord; 2020 Jan; 20(1):15. PubMed ID: 31931718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets.
    Bunescu A; Seideman P; Lenkei R; Levin K; Egberg N
    J Rheumatol; 2004 Dec; 31(12):2347-55. PubMed ID: 15570633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients.
    Yang S; Zhao J; Chen Y; Lei M
    Cardiovasc Toxicol; 2016 Jul; 16(3):213-22. PubMed ID: 26175178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects.
    Zuberi BF; Akhtar N; Afsar S
    Singapore Med J; 2008 Feb; 49(2):114-6. PubMed ID: 18301837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
    Zhang D; Zhang X; Liu D; Liu T; Cai W; Yan C; Han Y
    Cardiovasc Diabetol; 2016 Mar; 15():50. PubMed ID: 27005817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of platelet-leukocyte aggregation and platelet activation in stroke.
    Schmalbach B; Stepanow O; Jochens A; Riedel C; Deuschl G; Kuhlenbäumer G
    Cerebrovasc Dis; 2015; 39(3-4):176-80. PubMed ID: 25720421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
    Angiolillo DJ; Bernardo E; Capodanno D; Vivas D; Sabaté M; Ferreiro JL; Ueno M; Jimenez-Quevedo P; Alfonso F; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2010 Mar; 55(11):1139-46. PubMed ID: 20223369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy?
    Bavbek N; Kargili A; Kaftan O; Karakurt F; Kosar A; Akcay A
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):391-7. PubMed ID: 17911190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy.
    Hu H; Li N; Yngen M; Ostenson CG; Wallén NH; Hjemdahl P
    J Thromb Haemost; 2004 Jan; 2(1):58-64. PubMed ID: 14717967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria.
    Akinsegun A; Akinola Olusola D; Sarah JO; Olajumoke O; Adewumi A; Majeed O; Anthonia O; Ebele U; Olaitan O; Olanrewaju A; Kingsley A
    Pan Afr Med J; 2014; 18():42. PubMed ID: 25368731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean platelet volume in patients with type 2 diabetes mellitus.
    Papanas N; Symeonidis G; Maltezos E; Mavridis G; Karavageli E; Vosnakidis T; Lakasas G
    Platelets; 2004 Dec; 15(8):475-8. PubMed ID: 15763888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.